We and others have previously shown that epigenetic coregulators such as ZMYND8, CHD4, CARM1, TRIM24, and JMJD2C are frequently amplified or upregulated to promote breast cancer progression through their role in epigenetic reprogramming (37–42). Here, ZMYND8 is linked to breast carcinoma.